The PE Ratio as of November 2024 (TTM) for Adamis Pharmaceuticals Corporation (ADMP) is -0.08

According to Adamis Pharmaceuticals Corporation’s latest financial reports and current stock price. The company's current PE Ratio is -0.08. This represents a change of -100.48% compared to the average of 15.81 of the last 4 quarters.

Adamis Pharmaceuticals Corporation (ADMP) Historical PE Ratio (quarterly & annually)

How has ADMP PE Ratio performed in the past?

The mean historical PE Ratio of Adamis Pharmaceuticals Corporation over the last ten years is -3.58. The current -0.08 PE Ratio has changed 113.58% with respect to the historical average. Over the past ten years (40 quarters), ADMP's PE Ratio was at its highest in in the March 2023 quarter at 61.77. The PE Ratio was at its lowest in in the December 2016 quarter at -25.31.

Adamis Pharmaceuticals Corporation (ADMP) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Adamis Pharmaceuticals Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Adamis Pharmaceuticals Corporation (ADMP) Average PE Ratio

How has ADMP PE Ratio performed in the past?

The current PE Ratio of Adamis Pharmaceuticals Corporation (ADMP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Adamis Pharmaceuticals Corporation (ADMP) PE Ratio vs. Peers

How is ADMP’s PE Ratio compared to its peers?

Adamis Pharmaceuticals Corporation’s PE Ratio is less than Mallinckrodt plc (-0.04), less than Lifecore Biomedical, Inc. (34.50), greater than Lucy Scientific Discovery Inc. (-1.23), greater than Alimera Sciences, Inc. (-20.50), greater than Shuttle Pharmaceuticals Holdings, Inc. (-0.23), greater than Organogenesis Holdings Inc. (-72.75), greater than Catalent, Inc. (-26.87), greater than Tilray Brands, Inc. (-5.52), less than Aquestive Therapeutics, Inc. (0), greater than Evoke Pharma, Inc. (-11.80), greater than Guardion Health Sciences, Inc. (-0.99), less than AcelRx Pharmaceuticals, Inc. (0.65), greater than null (-2.52),

Build a custom stock screener for Adamis Pharmaceuticals Corporation (ADMP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Adamis Pharmaceuticals Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Adamis Pharmaceuticals Corporation (ADMP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Adamis Pharmaceuticals Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.